Results
|
|
141.
|
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole. [electronic resource] by
- Goss, P E
- Ingle, J N
- Martino, S
- Robert, N J
- Muss, H B
- Livingston, R B
- Davidson, N E
- Perez, E A
- Chavarri-Guerra, Y
- Cameron, D A
- Pritchard, K I
- Whelan, T
- Shepherd, L E
- Tu, D
Producer: 20130702
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
|
142.
|
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. [electronic resource] by
- Bonnefoi, H
- Litière, S
- Piccart, M
- MacGrogan, G
- Fumoleau, P
- Brain, E
- Petit, T
- Rouanet, P
- Jassem, J
- Moldovan, C
- Bodmer, A
- Zaman, K
- Cufer, T
- Campone, M
- Luporsi, E
- Malmström, P
- Werutsky, G
- Bogaerts, J
- Bergh, J
- Cameron, D A
Producer: 20150121
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
143.
|
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer. [electronic resource] by
- Stephen, J
- Murray, G
- Cameron, D A
- Thomas, J
- Kunkler, I H
- Jack, W
- Kerr, G R
- Piper, T
- Brookes, C L
- Rea, D W
- van de Velde, C J H
- Hasenburg, A
- Markopoulos, C
- Dirix, L
- Seynaeve, C
- Bartlett, J M S
Producer: 20150416
In:
British journal of cancer vol. 111
Availability: No items available.
|
|
|
144.
|
Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. [electronic resource] by
- Ali, H R
- Dariush, A
- Thomas, J
- Provenzano, E
- Dunn, J
- Hiller, L
- Vallier, A-L
- Abraham, J
- Piper, T
- Bartlett, J M S
- Cameron, D A
- Hayward, L
- Brenton, J D
- Pharoah, P D P
- Irwin, M J
- Walton, N A
- Earl, H M
- Caldas, C
Producer: 20180507
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
145.
|
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial. [electronic resource] by
- Earl, H M
- Hiller, L
- Dunn, J A
- Blenkinsop, C
- Grybowicz, L
- Vallier, A-L
- Gounaris, I
- Abraham, J E
- Hughes-Davies, L
- McAdam, K
- Chan, S
- Ahmad, R
- Hickish, T
- Rea, D
- Caldas, C
- Bartlett, J M S
- Cameron, D A
- Provenzano, E
- Thomas, J
- Hayward, R L
Producer: 20180507
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
146.
|
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. [electronic resource] by
- Ingle, J N
- Tu, D
- Pater, J L
- Muss, H B
- Martino, S
- Robert, N J
- Piccart, M J
- Castiglione, M
- Shepherd, L E
- Pritchard, K I
- Livingston, R B
- Davidson, N E
- Norton, L
- Perez, E A
- Abrams, J S
- Cameron, D A
- Palmer, M J
- Goss, P E
Producer: 20080624
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 19
Availability: No items available.
|
|
|
147.
|
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. [electronic resource] by
- Hortobagyi, G N
- Stemmer, S M
- Burris, H A
- Yap, Y S
- Sonke, G S
- Paluch-Shimon, S
- Campone, M
- Petrakova, K
- Blackwell, K L
- Winer, E P
- Janni, W
- Verma, S
- Conte, P
- Arteaga, C L
- Cameron, D A
- Mondal, S
- Su, F
- Miller, M
- Elmeliegy, M
- Germa, C
- O'Shaughnessy, J
Producer: 20191118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
148.
|
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. [electronic resource] by
- Hortobagyi, G N
- Stemmer, S M
- Burris, H A
- Yap, Y S
- Sonke, G S
- Paluch-Shimon, S
- Campone, M
- Petrakova, K
- Blackwell, K L
- Winer, E P
- Janni, W
- Verma, S
- Conte, P
- Arteaga, C L
- Cameron, D A
- Mondal, S
- Su, F
- Miller, M
- Elmeliegy, M
- Germa, C
- O'Shaughnessy, J
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 11 2019
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
|
149.
|
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group. [electronic resource] by
- Cameron, D A
- White, J M
- Proctor, S J
- Prescott, R J
- Leonard, R C
- Angus, B
- Cook, M K
- Dawes, P J
- Dawson, A A
- Evans, R G
- Galloway, M J
- Harris, A L
- Heppleston, A
- Horne, C H
- Krajewski, A S
- Lennard, A L
- Lessells, A M
- Lucraft, H H
- MacGillivray, J B
- Mackie, M J
- Parker, A C
- Roberts, J T
- Taylor, P R
- Thompson, W D
Producer: 19971008
In:
European journal of cancer (Oxford, England : 1990) vol. 33
Availability: No items available.
|